Welgene Biotech Co (ROCO:6661) Short-Term Capital Lease Obligation : NT$10.1 Mil (As of Mar. 2025)

View and export this data going back to 2017. Start your Free Trial

What is Welgene Biotech Co Short-Term Capital Lease Obligation?

Welgene Biotech Co's Short-Term Capital Lease Obligation for the quarter that ended in Mar. 2025 was NT$10.1 Mil.

Welgene Biotech Co's quarterly Short-Term Capital Lease Obligation increased from Sep. 2024 (NT$13.5 Mil) to Dec. 2024 (NT$13.6 Mil) but then declined from Dec. 2024 (NT$13.6 Mil) to Mar. 2025 (NT$10.1 Mil).

Welgene Biotech Co's annual Short-Term Capital Lease Obligation increased from Dec. 2022 (NT$13.1 Mil) to Dec. 2023 (NT$13.3 Mil) and increased from Dec. 2023 (NT$13.3 Mil) to Dec. 2024 (NT$13.6 Mil).

Welgene Biotech Co Short-Term Capital Lease Obligation Historical Data

The historical data trend for Welgene Biotech Co's Short-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Welgene Biotech Co Short-Term Capital Lease Obligation Chart

Welgene Biotech Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Short-Term Capital Lease Obligation

Get a 7-Day Free Trial

11.10

11.28

13.08

13.33

13.58

Welgene Biotech Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Short-Term Capital Lease Obligation	Get a 7-Day Free Trial															13.39	13.45	13.51	13.58	10.05

Welgene Biotech Co Short-Term Capital Lease Obligation Explanation

Short-Term Capital Lease Obligation represents the total amount of Long-Term Capital Lease Obligation that must be paid within the next accounting period. Capital lease obligations are contractual obligations that arise from obtaining the use of property or equipment via a capital lease contract.

Welgene Biotech Co Short-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Welgene Biotech Co's Short-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Welgene Biotech Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Welgene Biotech Co Ltd (ROCO:6661) » Definitions » Short-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 3, Yuanqu Street, 12th Floor, Nangang District, Taipei, TWN, 115

Website

https://www.welgene.com.tw

Welgene Biotech Co Ltd is engaged in providing clinical testing services. Its service and product offerings include next-generation sequencing service, agilent, welgene, OPS diagnostics products, and other products. The company also offers clinical testing agents and instruments.

Welgene Biotech Co Headlines

No Headlines